Matthew Keller
Concepts (476)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome-Wide Association Study | 44 | 2025 | 1395 | 4.900 |
Why?
| | Polymorphism, Single Nucleotide | 54 | 2025 | 2142 | 4.620 |
Why?
| | Biological Specimen Banks | 7 | 2025 | 100 | 4.130 |
Why?
| | Multifactorial Inheritance | 17 | 2025 | 170 | 3.170 |
Why?
| | Models, Genetic | 23 | 2025 | 586 | 3.130 |
Why?
| | Schizophrenia | 16 | 2022 | 443 | 2.980 |
Why?
| | Genetic Predisposition to Disease | 35 | 2025 | 2371 | 2.890 |
Why?
| | Gene-Environment Interaction | 9 | 2021 | 189 | 1.930 |
Why?
| | Homozygote | 11 | 2023 | 203 | 1.820 |
Why?
| | Genome, Human | 13 | 2021 | 419 | 1.730 |
Why?
| | Genetics, Population | 5 | 2022 | 209 | 1.690 |
Why?
| | Depressive Disorder, Major | 7 | 2022 | 368 | 1.670 |
Why?
| | Phenotype | 32 | 2025 | 3148 | 1.650 |
Why?
| | Genetic Variation | 19 | 2022 | 1000 | 1.560 |
Why?
| | Paternal Inheritance | 2 | 2021 | 3 | 1.390 |
Why?
| | Maternal Inheritance | 2 | 2021 | 16 | 1.380 |
Why?
| | Statistics as Topic | 3 | 2021 | 297 | 1.370 |
Why?
| | Dermatology | 3 | 2025 | 119 | 1.320 |
Why?
| | Consanguinity | 4 | 2018 | 49 | 1.230 |
Why?
| | United Kingdom | 9 | 2025 | 315 | 1.160 |
Why?
| | Mental Disorders | 12 | 2022 | 1089 | 1.150 |
Why?
| | Quantitative Trait, Heritable | 8 | 2025 | 124 | 1.130 |
Why?
| | Family | 7 | 2024 | 670 | 1.130 |
Why?
| | Sequence Analysis, DNA | 3 | 2017 | 824 | 1.110 |
Why?
| | Twins | 5 | 2021 | 222 | 1.110 |
Why?
| | Twins, Dizygotic | 6 | 2013 | 162 | 1.080 |
Why?
| | Humans | 143 | 2025 | 136965 | 1.060 |
Why?
| | Family Characteristics | 2 | 2025 | 191 | 1.050 |
Why?
| | Marriage | 3 | 2025 | 121 | 1.020 |
Why?
| | Genome | 3 | 2018 | 300 | 1.010 |
Why?
| | Cognition | 15 | 2022 | 1171 | 1.000 |
Why?
| | Academic Success | 2 | 2023 | 29 | 1.000 |
Why?
| | Twins, Monozygotic | 5 | 2013 | 189 | 0.980 |
Why?
| | Reproduction | 4 | 2022 | 205 | 0.940 |
Why?
| | Software | 3 | 2017 | 662 | 0.920 |
Why?
| | Smoking | 7 | 2025 | 1609 | 0.900 |
Why?
| | Family Health | 2 | 2024 | 194 | 0.900 |
Why?
| | Infant, Low Birth Weight | 1 | 2025 | 141 | 0.890 |
Why?
| | Environment | 5 | 2017 | 339 | 0.870 |
Why?
| | Spouses | 1 | 2025 | 104 | 0.870 |
Why?
| | Sexual Partners | 1 | 2025 | 188 | 0.840 |
Why?
| | Depression | 4 | 2022 | 1454 | 0.840 |
Why?
| | Linkage Disequilibrium | 6 | 2025 | 261 | 0.830 |
Why?
| | Genotype | 13 | 2021 | 1872 | 0.820 |
Why?
| | Genetics, Behavioral | 2 | 2020 | 34 | 0.810 |
Why?
| | Body Height | 6 | 2025 | 195 | 0.790 |
Why?
| | Biological Evolution | 4 | 2018 | 491 | 0.770 |
Why?
| | Mentors | 2 | 2025 | 209 | 0.760 |
Why?
| | Intelligence | 6 | 2025 | 127 | 0.750 |
Why?
| | Tobacco Use Disorder | 3 | 2025 | 241 | 0.710 |
Why?
| | Pedigree | 5 | 2024 | 510 | 0.690 |
Why?
| | Female | 74 | 2025 | 73002 | 0.690 |
Why?
| | Haplotypes | 4 | 2018 | 495 | 0.690 |
Why?
| | Computer Simulation | 7 | 2022 | 982 | 0.680 |
Why?
| | Educational Status | 8 | 2024 | 473 | 0.680 |
Why?
| | Inbreeding Depression | 2 | 2021 | 3 | 0.670 |
Why?
| | Male | 63 | 2025 | 67386 | 0.660 |
Why?
| | Algorithms | 3 | 2022 | 1700 | 0.650 |
Why?
| | Research Design | 6 | 2018 | 1114 | 0.630 |
Why?
| | Alleles | 10 | 2024 | 885 | 0.620 |
Why?
| | Twin Studies as Topic | 3 | 2018 | 19 | 0.620 |
Why?
| | Bias | 5 | 2022 | 222 | 0.610 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2025 | 604 | 0.600 |
Why?
| | Alcoholism | 6 | 2025 | 796 | 0.590 |
Why?
| | Cervical Length Measurement | 1 | 2018 | 4 | 0.580 |
Why?
| | Adult | 47 | 2025 | 37715 | 0.580 |
Why?
| | Psychological Trauma | 1 | 2019 | 54 | 0.570 |
Why?
| | Genomics | 9 | 2023 | 804 | 0.540 |
Why?
| | Tympanoplasty | 1 | 2017 | 8 | 0.540 |
Why?
| | Tympanic Membrane Perforation | 1 | 2017 | 17 | 0.540 |
Why?
| | Auditory Threshold | 1 | 2017 | 41 | 0.530 |
Why?
| | Blast Injuries | 1 | 2017 | 50 | 0.520 |
Why?
| | Beauty | 2 | 2013 | 19 | 0.520 |
Why?
| | Drug Eruptions | 1 | 2016 | 26 | 0.510 |
Why?
| | Third-Party Consent | 1 | 2016 | 20 | 0.510 |
Why?
| | Erlotinib Hydrochloride | 1 | 2016 | 68 | 0.510 |
Why?
| | Proxy | 1 | 2016 | 30 | 0.510 |
Why?
| | Psychotic Disorders | 2 | 2016 | 170 | 0.500 |
Why?
| | Adaptation, Physiological | 3 | 2018 | 549 | 0.490 |
Why?
| | Patient Acceptance of Health Care | 3 | 2021 | 843 | 0.490 |
Why?
| | Internship and Residency | 2 | 2025 | 1157 | 0.480 |
Why?
| | Genetic Loci | 9 | 2022 | 283 | 0.470 |
Why?
| | Creativity | 1 | 2015 | 16 | 0.470 |
Why?
| | Communication Barriers | 1 | 2016 | 111 | 0.470 |
Why?
| | Informed Consent | 1 | 2016 | 185 | 0.460 |
Why?
| | Nootropic Agents | 3 | 2021 | 28 | 0.460 |
Why?
| | Body Mass Index | 5 | 2024 | 2416 | 0.450 |
Why?
| | Socioeconomic Factors | 2 | 2019 | 1310 | 0.450 |
Why?
| | Likelihood Functions | 5 | 2022 | 143 | 0.430 |
Why?
| | Quantitative Trait Loci | 4 | 2024 | 375 | 0.430 |
Why?
| | Genealogy and Heraldry | 1 | 2013 | 5 | 0.420 |
Why?
| | Cocaine-Related Disorders | 1 | 2015 | 111 | 0.420 |
Why?
| | Telemedicine | 1 | 2022 | 863 | 0.400 |
Why?
| | Bipolar Disorder | 2 | 2015 | 263 | 0.400 |
Why?
| | Genetic Pleiotropy | 1 | 2013 | 30 | 0.400 |
Why?
| | Wearable Electronic Devices | 2 | 2025 | 53 | 0.400 |
Why?
| | Depressive Disorder | 2 | 2007 | 386 | 0.400 |
Why?
| | Metabolic Networks and Pathways | 1 | 2014 | 182 | 0.390 |
Why?
| | Dementia | 1 | 2016 | 264 | 0.390 |
Why?
| | Middle Aged | 31 | 2025 | 33226 | 0.390 |
Why?
| | Affect | 2 | 2005 | 306 | 0.390 |
Why?
| | Genes, Recessive | 1 | 2012 | 78 | 0.370 |
Why?
| | Marijuana Abuse | 1 | 2015 | 224 | 0.370 |
Why?
| | Inbreeding | 1 | 2011 | 18 | 0.360 |
Why?
| | Sex Characteristics | 2 | 2013 | 766 | 0.360 |
Why?
| | Gene Frequency | 6 | 2022 | 505 | 0.360 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 309 | 0.360 |
Why?
| | Risk Factors | 14 | 2025 | 10363 | 0.330 |
Why?
| | Substance-Related Disorders | 5 | 2025 | 1058 | 0.330 |
Why?
| | Social Environment | 4 | 2019 | 292 | 0.330 |
Why?
| | Adaptation, Psychological | 3 | 2022 | 669 | 0.330 |
Why?
| | Genetic Markers | 3 | 2020 | 346 | 0.330 |
Why?
| | Bariatric Surgery | 2 | 2024 | 215 | 0.330 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 102 | 0.320 |
Why?
| | Live Birth | 2 | 2020 | 65 | 0.320 |
Why?
| | Chromosomes, Human, Pair 2 | 1 | 2009 | 27 | 0.320 |
Why?
| | Uniparental Disomy | 1 | 2009 | 9 | 0.310 |
Why?
| | Models, Statistical | 5 | 2018 | 662 | 0.310 |
Why?
| | Negative-Pressure Wound Therapy | 2 | 2020 | 27 | 0.310 |
Why?
| | Life Change Events | 2 | 2007 | 149 | 0.310 |
Why?
| | Fathers | 1 | 2009 | 51 | 0.300 |
Why?
| | Registries | 2 | 2015 | 2048 | 0.300 |
Why?
| | Personality | 2 | 2012 | 125 | 0.300 |
Why?
| | Stillbirth | 2 | 2019 | 72 | 0.300 |
Why?
| | Aged | 16 | 2025 | 23803 | 0.300 |
Why?
| | Dysphonia | 2 | 2018 | 15 | 0.290 |
Why?
| | Models, Theoretical | 3 | 2021 | 581 | 0.290 |
Why?
| | Psychiatry | 1 | 2011 | 184 | 0.290 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 4 | 2025 | 238 | 0.290 |
Why?
| | Laryngeal Diseases | 2 | 2018 | 29 | 0.290 |
Why?
| | Parkinson Disease | 2 | 2025 | 542 | 0.290 |
Why?
| | Psoriasis | 2 | 2021 | 101 | 0.290 |
Why?
| | Young Adult | 18 | 2025 | 13218 | 0.290 |
Why?
| | Mendelian Randomization Analysis | 3 | 2024 | 49 | 0.280 |
Why?
| | Evolution, Molecular | 2 | 2017 | 514 | 0.280 |
Why?
| | Genetic Association Studies | 4 | 2019 | 370 | 0.280 |
Why?
| | Inheritance Patterns | 4 | 2021 | 44 | 0.280 |
Why?
| | Parent-Child Relations | 2 | 2021 | 278 | 0.270 |
Why?
| | Adolescent | 26 | 2025 | 21471 | 0.270 |
Why?
| | Myeloproliferative Disorders | 2 | 2019 | 27 | 0.270 |
Why?
| | Chromosomes, Human | 3 | 2018 | 44 | 0.270 |
Why?
| | Retrospective Studies | 16 | 2022 | 15536 | 0.270 |
Why?
| | Computational Biology | 1 | 2011 | 647 | 0.260 |
Why?
| | Pediatric Obesity | 2 | 2024 | 612 | 0.250 |
Why?
| | Chromosome Mapping | 3 | 2015 | 514 | 0.250 |
Why?
| | Neurodevelopmental Disorders | 2 | 2019 | 182 | 0.240 |
Why?
| | Pregnancy | 7 | 2025 | 6736 | 0.240 |
Why?
| | Reproducibility of Results | 4 | 2019 | 3266 | 0.240 |
Why?
| | Selection, Genetic | 2 | 2012 | 271 | 0.230 |
Why?
| | Surveys and Questionnaires | 6 | 2025 | 5812 | 0.230 |
Why?
| | Weather | 1 | 2005 | 40 | 0.230 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2111 | 0.230 |
Why?
| | Pregnancy Complications, Neoplastic | 1 | 2025 | 53 | 0.230 |
Why?
| | Tobacco Products | 2 | 2024 | 135 | 0.230 |
Why?
| | Biofeedback, Psychology | 1 | 2025 | 36 | 0.230 |
Why?
| | Executive Function | 2 | 2022 | 450 | 0.220 |
Why?
| | Pregnancy Complications | 2 | 2019 | 526 | 0.220 |
Why?
| | Apolipoproteins E | 1 | 2024 | 82 | 0.210 |
Why?
| | Alcohol Drinking | 2 | 2022 | 813 | 0.210 |
Why?
| | Recombination, Genetic | 2 | 2016 | 207 | 0.210 |
Why?
| | Cognition Disorders | 2 | 2019 | 502 | 0.200 |
Why?
| | Deglutition Disorders | 1 | 2025 | 141 | 0.200 |
Why?
| | Hidradenitis Suppurativa | 1 | 2022 | 9 | 0.200 |
Why?
| | Ureteral Calculi | 1 | 2022 | 15 | 0.200 |
Why?
| | Parents | 2 | 2022 | 1412 | 0.190 |
Why?
| | Lithotripsy | 1 | 2022 | 45 | 0.190 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2022 | 38 | 0.190 |
Why?
| | Population Health | 1 | 2023 | 48 | 0.190 |
Why?
| | Face | 2 | 2013 | 171 | 0.190 |
Why?
| | Birth Weight | 1 | 2025 | 508 | 0.190 |
Why?
| | Tobacco Use | 1 | 2022 | 63 | 0.190 |
Why?
| | Faculty, Medical | 1 | 2025 | 287 | 0.190 |
Why?
| | Compartment Syndromes | 1 | 2022 | 25 | 0.190 |
Why?
| | Receptors, Nicotinic | 2 | 2025 | 344 | 0.190 |
Why?
| | Internationality | 1 | 2022 | 158 | 0.180 |
Why?
| | Fractures, Open | 1 | 2022 | 29 | 0.180 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 3 | 2022 | 416 | 0.180 |
Why?
| | Health Care Costs | 2 | 2022 | 398 | 0.180 |
Why?
| | Mutation, Missense | 2 | 2019 | 338 | 0.180 |
Why?
| | Arthritis, Psoriatic | 1 | 2021 | 21 | 0.180 |
Why?
| | Tibial Fractures | 1 | 2022 | 68 | 0.180 |
Why?
| | Respiratory Rate | 1 | 2021 | 19 | 0.180 |
Why?
| | Wireless Technology | 1 | 2021 | 13 | 0.180 |
Why?
| | Artificial Intelligence | 1 | 2025 | 291 | 0.180 |
Why?
| | Gastric Bypass | 1 | 2022 | 115 | 0.170 |
Why?
| | Genotyping Techniques | 2 | 2018 | 74 | 0.170 |
Why?
| | Tremor | 2 | 2018 | 98 | 0.170 |
Why?
| | Pregnancy, Twin | 1 | 2020 | 19 | 0.170 |
Why?
| | Inpatients | 2 | 2022 | 496 | 0.170 |
Why?
| | Respiratory Sounds | 1 | 2021 | 109 | 0.170 |
Why?
| | Arthroplasty, Replacement | 1 | 2021 | 46 | 0.170 |
Why?
| | Hospitalization | 5 | 2021 | 2182 | 0.160 |
Why?
| | Hysterectomy | 1 | 2021 | 131 | 0.160 |
Why?
| | Mental Health | 2 | 2024 | 733 | 0.160 |
Why?
| | Behavior, Addictive | 1 | 2020 | 80 | 0.160 |
Why?
| | Medicaid | 2 | 2021 | 437 | 0.160 |
Why?
| | Maternal Health | 1 | 2019 | 49 | 0.150 |
Why?
| | Duffy Blood-Group System | 1 | 2019 | 6 | 0.150 |
Why?
| | Florida | 4 | 2019 | 107 | 0.150 |
Why?
| | History, 21st Century | 1 | 2020 | 213 | 0.150 |
Why?
| | Friends | 1 | 2019 | 53 | 0.150 |
Why?
| | Exotoxins | 1 | 2019 | 16 | 0.150 |
Why?
| | Janus Kinase 2 | 1 | 2019 | 31 | 0.150 |
Why?
| | Orbital Cellulitis | 1 | 2019 | 17 | 0.150 |
Why?
| | Cone Opsins | 1 | 2018 | 2 | 0.150 |
Why?
| | Siblings | 2 | 2013 | 215 | 0.150 |
Why?
| | Minisatellite Repeats | 1 | 2019 | 41 | 0.150 |
Why?
| | Hemolysin Proteins | 1 | 2019 | 35 | 0.150 |
Why?
| | Dermatitis, Atopic | 1 | 2022 | 327 | 0.150 |
Why?
| | Laryngismus | 1 | 2018 | 10 | 0.150 |
Why?
| | History, 20th Century | 1 | 2020 | 324 | 0.150 |
Why?
| | Chronic Pain | 1 | 2023 | 271 | 0.150 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2018 | 20 | 0.150 |
Why?
| | Antimicrobial Stewardship | 1 | 2021 | 117 | 0.150 |
Why?
| | Obesity, Morbid | 1 | 2022 | 262 | 0.150 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2019 | 58 | 0.150 |
Why?
| | Time-to-Treatment | 1 | 2020 | 203 | 0.150 |
Why?
| | Urinary Tract Infections | 1 | 2021 | 187 | 0.150 |
Why?
| | Bacterial Toxins | 1 | 2019 | 104 | 0.150 |
Why?
| | Laparoscopy | 1 | 2022 | 434 | 0.140 |
Why?
| | Recurrence | 2 | 2019 | 1059 | 0.140 |
Why?
| | Follow-Up Studies | 4 | 2025 | 5048 | 0.140 |
Why?
| | Lasers | 1 | 2018 | 129 | 0.140 |
Why?
| | Pregnancy Trimester, Second | 1 | 2018 | 79 | 0.140 |
Why?
| | Europe | 2 | 2022 | 403 | 0.140 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2809 | 0.140 |
Why?
| | Needs Assessment | 1 | 2020 | 380 | 0.140 |
Why?
| | Cohort Studies | 6 | 2022 | 5688 | 0.140 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2020 | 177 | 0.140 |
Why?
| | Education, Medical, Graduate | 1 | 2022 | 483 | 0.140 |
Why?
| | Neuromuscular Agents | 1 | 2018 | 37 | 0.140 |
Why?
| | Pneumonia, Viral | 1 | 2022 | 367 | 0.140 |
Why?
| | Audiometry, Pure-Tone | 1 | 2017 | 30 | 0.140 |
Why?
| | Botulinum Toxins, Type A | 1 | 2018 | 48 | 0.130 |
Why?
| | Databases, Factual | 4 | 2025 | 1367 | 0.130 |
Why?
| | Heart Rate | 1 | 2021 | 794 | 0.130 |
Why?
| | Mouth | 1 | 2017 | 87 | 0.130 |
Why?
| | Event-Related Potentials, P300 | 1 | 2016 | 14 | 0.130 |
Why?
| | Synaptic Transmission | 1 | 2019 | 289 | 0.130 |
Why?
| | Neurocognitive Disorders | 1 | 2017 | 29 | 0.130 |
Why?
| | Endophenotypes | 1 | 2016 | 20 | 0.130 |
Why?
| | Patient Discharge | 2 | 2022 | 901 | 0.130 |
Why?
| | MAP Kinase Signaling System | 1 | 2019 | 321 | 0.130 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 157 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2017 | 3556 | 0.130 |
Why?
| | Parenting | 1 | 2020 | 315 | 0.130 |
Why?
| | Patient Readmission | 1 | 2022 | 699 | 0.130 |
Why?
| | Receptors, Cell Surface | 1 | 2019 | 391 | 0.130 |
Why?
| | Postpartum Period | 1 | 2019 | 340 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2022 | 779 | 0.130 |
Why?
| | Phylogeny | 1 | 2021 | 1003 | 0.130 |
Why?
| | Retina | 1 | 2018 | 296 | 0.120 |
Why?
| | Influenza, Human | 1 | 2022 | 611 | 0.120 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 138 | 0.120 |
Why?
| | Regression Analysis | 3 | 2021 | 1007 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2019 | 634 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2019 | 427 | 0.120 |
Why?
| | DNA Copy Number Variations | 1 | 2016 | 177 | 0.120 |
Why?
| | Ambulatory Care | 1 | 2020 | 567 | 0.120 |
Why?
| | Telephone | 1 | 2016 | 179 | 0.120 |
Why?
| | Pityriasis Rubra Pilaris | 1 | 2015 | 1 | 0.120 |
Why?
| | Curriculum | 1 | 2022 | 998 | 0.120 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2020 | 362 | 0.120 |
Why?
| | Aged, 80 and over | 5 | 2019 | 7559 | 0.120 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2015 | 21 | 0.120 |
Why?
| | Guanylate Cyclase | 1 | 2015 | 37 | 0.110 |
Why?
| | Genetic Research | 1 | 2015 | 16 | 0.110 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1923 | 0.110 |
Why?
| | Staphylococcus aureus | 1 | 2019 | 431 | 0.110 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2015 | 126 | 0.110 |
Why?
| | Comprehension | 1 | 2016 | 174 | 0.110 |
Why?
| | United States | 7 | 2025 | 14945 | 0.110 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 383 | 0.110 |
Why?
| | Principal Component Analysis | 1 | 2015 | 192 | 0.110 |
Why?
| | Adolescent Behavior | 1 | 2019 | 533 | 0.110 |
Why?
| | Comorbidity | 2 | 2019 | 1626 | 0.110 |
Why?
| | Masculinity | 1 | 2013 | 9 | 0.110 |
Why?
| | Membrane Proteins | 2 | 2024 | 1151 | 0.110 |
Why?
| | Genetic Testing | 1 | 2017 | 455 | 0.110 |
Why?
| | Infant, Newborn | 1 | 2025 | 6051 | 0.110 |
Why?
| | Genetic Fitness | 1 | 2014 | 59 | 0.110 |
Why?
| | Antisocial Personality Disorder | 1 | 2015 | 152 | 0.100 |
Why?
| | Stress, Psychological | 1 | 2022 | 1114 | 0.100 |
Why?
| | Impulsive Behavior | 1 | 2015 | 148 | 0.100 |
Why?
| | Endothelial Cells | 1 | 2019 | 784 | 0.100 |
Why?
| | Africa | 1 | 2013 | 116 | 0.100 |
Why?
| | Tumor Suppressor Proteins | 1 | 2015 | 323 | 0.100 |
Why?
| | Interpersonal Relations | 2 | 2008 | 406 | 0.100 |
Why?
| | Outpatients | 1 | 2016 | 405 | 0.100 |
Why?
| | Biopsy | 1 | 2016 | 1083 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2019 | 901 | 0.100 |
Why?
| | Breast Neoplasms | 1 | 2025 | 2266 | 0.100 |
Why?
| | Bacterial Proteins | 1 | 2019 | 895 | 0.100 |
Why?
| | Treatment Outcome | 4 | 2022 | 10664 | 0.100 |
Why?
| | Adolescent Development | 1 | 2013 | 88 | 0.100 |
Why?
| | Anxiety Disorders | 1 | 2016 | 375 | 0.100 |
Why?
| | Hematopoietic Stem Cells | 1 | 2015 | 407 | 0.090 |
Why?
| | Choice Behavior | 1 | 2013 | 172 | 0.090 |
Why?
| | Physician-Patient Relations | 1 | 2016 | 577 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 616 | 0.090 |
Why?
| | Cell Cycle Proteins | 1 | 2015 | 614 | 0.090 |
Why?
| | Parathyroid Glands | 1 | 2011 | 10 | 0.090 |
Why?
| | Virginia | 2 | 2009 | 63 | 0.090 |
Why?
| | Population Density | 1 | 2011 | 96 | 0.090 |
Why?
| | Life Style | 2 | 2021 | 490 | 0.090 |
Why?
| | NF-kappa B | 1 | 2015 | 676 | 0.090 |
Why?
| | Spectroscopy, Near-Infrared | 1 | 2011 | 59 | 0.090 |
Why?
| | Child | 9 | 2024 | 21760 | 0.090 |
Why?
| | Spectrometry, Fluorescence | 1 | 2011 | 168 | 0.080 |
Why?
| | Military Personnel | 1 | 2017 | 545 | 0.080 |
Why?
| | Anthropometry | 2 | 2024 | 213 | 0.080 |
Why?
| | Microbiota | 1 | 2017 | 759 | 0.080 |
Why?
| | Sexual Behavior | 1 | 2013 | 487 | 0.080 |
Why?
| | Decision Making | 1 | 2016 | 935 | 0.080 |
Why?
| | International Classification of Diseases | 2 | 2019 | 136 | 0.070 |
Why?
| | Child Development | 1 | 2013 | 466 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2024 | 2851 | 0.070 |
Why?
| | Risk | 3 | 2019 | 901 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2016 | 848 | 0.070 |
Why?
| | Prevalence | 1 | 2015 | 2732 | 0.070 |
Why?
| | Databases, Genetic | 1 | 2009 | 239 | 0.070 |
Why?
| | Thinking | 1 | 2008 | 68 | 0.070 |
Why?
| | Personality Inventory | 1 | 2007 | 137 | 0.070 |
Why?
| | Health Status | 2 | 2024 | 817 | 0.070 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2011 | 746 | 0.060 |
Why?
| | Incidence | 2 | 2025 | 2793 | 0.060 |
Why?
| | Analysis of Variance | 3 | 2018 | 1301 | 0.060 |
Why?
| | Diseases in Twins | 1 | 2007 | 159 | 0.060 |
Why?
| | Arthritis, Rheumatoid | 1 | 2015 | 1156 | 0.060 |
Why?
| | Gestational Age | 2 | 2019 | 902 | 0.060 |
Why?
| | Proportional Hazards Models | 2 | 2019 | 1251 | 0.060 |
Why?
| | Length of Stay | 2 | 2022 | 1192 | 0.060 |
Why?
| | Personality Assessment | 1 | 2005 | 83 | 0.060 |
Why?
| | Transcriptome | 2 | 2022 | 966 | 0.060 |
Why?
| | Genetic Techniques | 1 | 2006 | 67 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2574 | 0.060 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2007 | 549 | 0.060 |
Why?
| | Ectodermal Dysplasia | 1 | 2005 | 18 | 0.060 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 2080 | 0.060 |
Why?
| | Norway | 1 | 2024 | 42 | 0.060 |
Why?
| | Connexin 43 | 1 | 2005 | 32 | 0.060 |
Why?
| | Connexins | 1 | 2005 | 48 | 0.060 |
Why?
| | Social Isolation | 1 | 2005 | 61 | 0.060 |
Why?
| | Australia | 1 | 2005 | 316 | 0.060 |
Why?
| | Mastectomy | 1 | 2025 | 139 | 0.050 |
Why?
| | Chromosomes, Human, Pair 20 | 1 | 2024 | 17 | 0.050 |
Why?
| | Mammaplasty | 1 | 2025 | 107 | 0.050 |
Why?
| | Child, Preschool | 4 | 2020 | 10952 | 0.050 |
Why?
| | Ureteroscopy | 1 | 2022 | 14 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 265 | 0.050 |
Why?
| | Sample Size | 1 | 2022 | 124 | 0.050 |
Why?
| | Social Behavior | 2 | 2019 | 288 | 0.050 |
Why?
| | Pruritus | 1 | 2022 | 61 | 0.050 |
Why?
| | Paralysis | 1 | 2022 | 72 | 0.050 |
Why?
| | Lumbar Vertebrae | 1 | 2024 | 247 | 0.050 |
Why?
| | Nerve Tissue Proteins | 1 | 2025 | 592 | 0.040 |
Why?
| | Upper Extremity | 1 | 2022 | 100 | 0.040 |
Why?
| | Hand | 1 | 2022 | 154 | 0.040 |
Why?
| | Infant | 3 | 2020 | 9392 | 0.040 |
Why?
| | Brain | 3 | 2023 | 2711 | 0.040 |
Why?
| | Gene Expression | 1 | 2006 | 1480 | 0.040 |
Why?
| | Tibia | 1 | 2022 | 178 | 0.040 |
Why?
| | Animals | 6 | 2019 | 36882 | 0.040 |
Why?
| | Students, Medical | 1 | 2025 | 351 | 0.040 |
Why?
| | Inappropriate Prescribing | 1 | 2021 | 57 | 0.040 |
Why?
| | Bone Density | 1 | 2024 | 488 | 0.040 |
Why?
| | Mutation | 1 | 2011 | 3975 | 0.040 |
Why?
| | Social Sciences | 1 | 2019 | 8 | 0.040 |
Why?
| | Body Weight | 1 | 2024 | 985 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1730 | 0.040 |
Why?
| | Nebraska | 1 | 2019 | 18 | 0.040 |
Why?
| | Arkansas | 1 | 2019 | 17 | 0.040 |
Why?
| | Iowa | 1 | 2019 | 30 | 0.040 |
Why?
| | Receptors, Thrombopoietin | 1 | 2019 | 6 | 0.040 |
Why?
| | Maryland | 1 | 2019 | 59 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2011 | 2115 | 0.040 |
Why?
| | Monitoring, Physiologic | 1 | 2021 | 266 | 0.040 |
Why?
| | Wisconsin | 1 | 2019 | 104 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 29 | 0.040 |
Why?
| | New York | 1 | 2019 | 123 | 0.040 |
Why?
| | Ophthalmoscopy | 1 | 2018 | 38 | 0.040 |
Why?
| | Infrared Rays | 1 | 2018 | 26 | 0.040 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2019 | 92 | 0.040 |
Why?
| | Macaca fascicularis | 1 | 2018 | 68 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor alpha | 1 | 2019 | 44 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 522 | 0.040 |
Why?
| | Biometry | 1 | 2018 | 68 | 0.040 |
Why?
| | Morbidity | 1 | 2019 | 319 | 0.040 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2018 | 68 | 0.040 |
Why?
| | Laryngeal Muscles | 1 | 2018 | 12 | 0.040 |
Why?
| | Voice Quality | 1 | 2018 | 22 | 0.040 |
Why?
| | Cefotaxime | 1 | 2017 | 2 | 0.040 |
Why?
| | Counseling | 1 | 2021 | 392 | 0.040 |
Why?
| | Alzheimer Disease | 1 | 2024 | 567 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2019 | 304 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 388 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 373 | 0.030 |
Why?
| | Injections, Intramuscular | 1 | 2018 | 129 | 0.030 |
Why?
| | Peer Group | 1 | 2019 | 244 | 0.030 |
Why?
| | Hospitals | 1 | 2022 | 689 | 0.030 |
Why?
| | Acute Disease | 1 | 2020 | 993 | 0.030 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 521 | 0.030 |
Why?
| | Contactins | 1 | 2016 | 2 | 0.030 |
Why?
| | Weight Loss | 1 | 2022 | 783 | 0.030 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 416 | 0.030 |
Why?
| | Odds Ratio | 1 | 2019 | 1071 | 0.030 |
Why?
| | Saccades | 1 | 2016 | 41 | 0.030 |
Why?
| | Mice | 3 | 2019 | 17705 | 0.030 |
Why?
| | Reaction Time | 1 | 2018 | 416 | 0.030 |
Why?
| | Linear Models | 2 | 2012 | 857 | 0.030 |
Why?
| | Mothers | 1 | 2022 | 758 | 0.030 |
Why?
| | Alcohol Abstinence | 1 | 2015 | 13 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 5530 | 0.030 |
Why?
| | Drug Delivery Systems | 1 | 2019 | 356 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 1278 | 0.030 |
Why?
| | Cell Survival | 1 | 2019 | 1124 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2016 | 186 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1441 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1484 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2015 | 290 | 0.030 |
Why?
| | Finland | 1 | 2014 | 85 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 1039 | 0.030 |
Why?
| | Rare Diseases | 1 | 2015 | 105 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 2066 | 0.030 |
Why?
| | Genetic Phenomena | 1 | 2013 | 8 | 0.030 |
Why?
| | Electroencephalography | 1 | 2016 | 433 | 0.030 |
Why?
| | Synapses | 1 | 2017 | 415 | 0.030 |
Why?
| | Genetic Heterogeneity | 1 | 2013 | 59 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2060 | 0.020 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 62 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2015 | 371 | 0.020 |
Why?
| | Conduct Disorder | 1 | 2015 | 186 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2021 | 1295 | 0.020 |
Why?
| | Risk-Taking | 1 | 2015 | 343 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 2999 | 0.020 |
Why?
| | Molecular Sequence Annotation | 1 | 2012 | 99 | 0.020 |
Why?
| | Chromatin | 1 | 2015 | 516 | 0.020 |
Why?
| | Age Factors | 1 | 2019 | 3258 | 0.020 |
Why?
| | Parathyroidectomy | 1 | 2011 | 9 | 0.020 |
Why?
| | Models, Biological | 1 | 2019 | 1780 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2019 | 4136 | 0.020 |
Why?
| | Thyroid Diseases | 1 | 2011 | 35 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3393 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3931 | 0.020 |
Why?
| | Risk Assessment | 1 | 2020 | 3446 | 0.020 |
Why?
| | Thyroidectomy | 1 | 2011 | 95 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2021 | 1784 | 0.020 |
Why?
| | Pediatrics | 1 | 2018 | 1061 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2022 | 2622 | 0.020 |
Why?
| | Surgery, Computer-Assisted | 1 | 2011 | 72 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4542 | 0.020 |
Why?
| | Central Nervous System | 1 | 2012 | 262 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4095 | 0.020 |
Why?
| | Crohn Disease | 1 | 2013 | 244 | 0.020 |
Why?
| | Time Factors | 1 | 2020 | 6786 | 0.020 |
Why?
| | Trachea | 1 | 2011 | 247 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4035 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 1046 | 0.020 |
Why?
| | Clinical Trials as Topic | 1 | 2014 | 1019 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 4276 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2015 | 1985 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2011 | 642 | 0.020 |
Why?
| | Connexin 26 | 1 | 2005 | 8 | 0.010 |
Why?
| | Roma | 1 | 2005 | 2 | 0.010 |
Why?
| | Least-Squares Analysis | 1 | 2005 | 79 | 0.010 |
Why?
| | False Positive Reactions | 1 | 2005 | 112 | 0.010 |
Why?
| | Motor Cortex | 1 | 2005 | 61 | 0.010 |
Why?
| | Data Collection | 1 | 2008 | 666 | 0.010 |
Why?
| | Interviews as Topic | 1 | 2008 | 801 | 0.010 |
Why?
| | Functional Laterality | 1 | 2005 | 226 | 0.010 |
Why?
| | DNA Mutational Analysis | 1 | 2005 | 395 | 0.010 |
Why?
| | Psychomotor Performance | 1 | 2005 | 310 | 0.010 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1045 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 5047 | 0.010 |
Why?
| | Pain | 1 | 2005 | 750 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2005 | 3574 | 0.010 |
Why?
|
|
Keller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|